Boston Scientific Corp. BSX
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $20.1B | +20% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $13.9B | +21% | FY ending Dec 31, 2025 |
| Operating income | $3.6B | +39% | FY ending Dec 31, 2025 |
| Net income | $2.9B | +57% | FY ending Dec 31, 2025 |
| Earnings per share | $1.94 | +55% | FY ending Dec 31, 2025 |
| Research & development | $2.1B | +27% | FY ending Dec 31, 2025 |
| Cash from operations | $4.5B | +32% | FY ending Dec 31, 2025 |
| Capital spending | $876.0M | +11% | FY ending Dec 31, 2025 |
| Share buybacks | $0 | FY ending Dec 31, 2022 | |
| Dividends paid | $0 | -100% | FY ending Dec 31, 2024 |
| Cash | $2.0B | +375% | FY ending Dec 31, 2025 |
| Long-term debt | $3.8B | -30% | FY ending Dec 31, 2017 |
| Shareholders' equity | $24.2B | +11% | FY ending Dec 31, 2025 |
| Shares outstanding | 1.39B | +1% | FY ending Dec 31, 2019 |
Insider trades
Last 12 months: 10 open-market buys ($10.0M) and 4 sales ($23.0M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Susan E MoranoDirector | Bought | 2,040 | $49.22 | $100K | Aug 25, 2026 |
| David C HabigerDirector | Bought | 2,100 | $47.59 | $100K | Aug 5, 2026 |
| David C HabigerDirector | Bought | 140 | $48.59 | $6,802 | Aug 4, 2026 |
| Michael F MahoneyChairman, President & CEO, Director | Bought | 186,240 | $48.33 | $9.0M | Aug 3, 2026 |
| David C HabigerDirector | Bought | 1,042 | $48.07 | $50K | Aug 3, 2026 |
| Edward J LudwigDirector | Bought | 5,000 | $45.48 | $227K | Jul 31, 2026 |
| Edward J LudwigDirector | Bought | 3,580 | $56.68 | $203K | May 20, 2026 |
| David C HabigerDirector | Bought | 2,250 | $55.92 | $126K | May 20, 2026 |
| Cheryl PegusDirector | Bought | 1,770 | $56.49 | $100K | May 20, 2026 |
| David C HabigerDirector | Bought | 2,200 | $56.95 | $125K | May 19, 2026 |
| Michael F MahoneyChairman, President & CEO, Director | Soldpre-set plan2 fills | 160,901 | $93.49 avg | $15.0M | Feb 2, 2026 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | Soldpre-set plan | 17,313 | $101.55 | $1.8M | Dec 1, 2025 |
| Ellen M ZaneDirector | Soldpre-set plan | 12,891 | $98.28 | $1.3M | Nov 6, 2025 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Soldpre-set plan3 fills | 50,000 | $99.47 avg | $5.0M | Nov 3, 2025 |
Other insider moves (102): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Padraig Andrew O'ConnorEVP, Global Operations | Tax withholding | 567 | $48.37 | $27K | Sep 2, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Option exercise | 1,171 | – | – | Sep 2, 2026 |
| Emily WoodworthSVP, Global Controller and CAO | I | 2,930 | $51.19 | $150K | Aug 11, 2026 |
| Jonathan MonsonEVP and CFO | I | 9,908 | $50.46 | $500K | Aug 10, 2026 |
| Michael F MahoneyChairman, President & CEO, Director | I | 22,119 | $48.43 | $1.1M | Aug 3, 2026 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | I | 64,198 | $46.73 | $3.0M | Jul 31, 2026 |
| Jonathan MonsonEVP and CFO | Tax withholding | 1,010 | $43.06 | $43K | Jul 1, 2026 |
| Jonathan MonsonEVP and CFO | Option exercise | 2,087 | – | – | Jul 1, 2026 |
| Michael F MahoneyChairman, President & CEO, Director | Gift | 386,755 | – | – | May 28, 2026 |
| Ellen M ZaneDirector | Award | 3,800 | – | – | May 7, 2026 |
| David S WichmannDirector | Award | 3,800 | – | – | May 7, 2026 |
| Christophe Pierre WeberDirector | Award2 fills | 2,907 | – | – | May 7, 2026 |
| Susan E MoranoDirector | Award2 fills | 5,081 | – | – | May 7, 2026 |
| Jessica L MegaDirector | Award | 3,800 | – | – | May 7, 2026 |
| Edward J LudwigDirector | Award | 3,800 | – | – | May 7, 2026 |
| David C HabigerDirector | Award | 3,800 | – | – | May 7, 2026 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | Tax withholding | 1,007 | $56.50 | $57K | May 2, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Tax withholding | 872 | $56.50 | $49K | May 2, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Option exercise | 1,802 | – | – | May 2, 2026 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | Option exercise | 2,102 | – | – | May 2, 2026 |
| Susan E MoranoDirector | Award | 24 | – | – | Mar 2, 2026 |
| Christophe Pierre WeberDirector | Award2 fills | 879 | – | – | Mar 2, 2026 |
| Emily WoodworthSVP, Global Controller and CAO | Tax withholding | 372 | $76.85 | $29K | Mar 1, 2026 |
| Emily WoodworthSVP, Global Controller and CAO | Option exercise | 838 | – | – | Mar 1, 2026 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | I | 6,851 | $75.76 | $519K | Feb 19, 2026 |
| Michael F MahoneyChairman, President & CEO, Director | Tax withholding | 7,865 | $74.73 | $588K | Feb 16, 2026 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Tax withholding | 1,806 | $74.73 | $135K | Feb 16, 2026 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | Tax withholding | 1,229 | $74.73 | $92K | Feb 16, 2026 |
| Vance R BrownEVP, GC and Corp. Secretary | Tax withholding | 890 | $74.73 | $67K | Feb 16, 2026 |
| Jonathan MonsonEVP and CFO | Tax withholding | 440 | $74.73 | $33K | Feb 16, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Tax withholding | 339 | $74.73 | $25K | Feb 16, 2026 |
| Miriam O'SullivanSVP, Chief HR Officer | Tax withholding | 291 | $74.73 | $22K | Feb 16, 2026 |
| Emily WoodworthSVP, Global Controller and CAO | Tax withholding | 283 | $74.73 | $21K | Feb 16, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Option exercise | 905 | – | – | Feb 16, 2026 |
| Emily WoodworthSVP, Global Controller and CAO | Option exercise | 637 | – | – | Feb 16, 2026 |
| Jonathan MonsonEVP and CFO | Option exercise | 990 | – | – | Feb 16, 2026 |
| Miriam O'SullivanSVP, Chief HR Officer | Option exercise | 990 | – | – | Feb 16, 2026 |
| Michael F MahoneyChairman, President & CEO, Director | Option exercise | 16,265 | – | – | Feb 16, 2026 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Option exercise | 3,960 | – | – | Feb 16, 2026 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | Option exercise | 2,546 | – | – | Feb 16, 2026 |
| Vance R BrownEVP, GC and Corp. Secretary | Option exercise | 1,839 | – | – | Feb 16, 2026 |
| Michael F MahoneyChairman, President & CEO, Director | Tax withholding | 7,990 | $74.73 | $597K | Feb 14, 2026 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Tax withholding | 1,990 | $74.73 | $149K | Feb 14, 2026 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | Tax withholding | 1,535 | $74.73 | $115K | Feb 14, 2026 |
| Vance R BrownEVP, GC and Corp. Secretary | Tax withholding | 895 | $74.73 | $67K | Feb 14, 2026 |
| Jonathan MonsonEVP and CFO | Tax withholding | 470 | $74.73 | $35K | Feb 14, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Tax withholding | 449 | $74.73 | $34K | Feb 14, 2026 |
| Miriam O'SullivanSVP, Chief HR Officer | Tax withholding | 329 | $74.73 | $25K | Feb 14, 2026 |
| Emily WoodworthSVP, Global Controller and CAO | Tax withholding | 296 | $74.73 | $22K | Feb 14, 2026 |
| Padraig Andrew O'ConnorEVP, Global Operations | Option exercise | 1,190 | – | – | Feb 14, 2026 |
| Emily WoodworthSVP, Global Controller and CAO | Option exercise | 661 | – | – | Feb 14, 2026 |
| Jonathan MonsonEVP and CFO | Option exercise | 1,058 | – | – | Feb 14, 2026 |
| Miriam O'SullivanSVP, Chief HR Officer | Option exercise | 1,124 | – | – | Feb 14, 2026 |
| Michael F MahoneyChairman, President & CEO, Director | Option exercise | 16,524 | – | – | Feb 14, 2026 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Option exercise | 4,362 | – | – | Feb 14, 2026 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | Option exercise | 3,173 | – | – | Feb 14, 2026 |
| Vance R BrownEVP, GC and Corp. Secretary | Option exercise | 1,851 | – | – | Feb 14, 2026 |
| Michael F MahoneyChairman, President & CEO, Director | Tax withholding | 132,099 | $74.73 | $9.9M | Feb 13, 2026 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Tax withholding | 33,104 | $74.73 | $2.5M | Feb 13, 2026 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | Tax withholding | 25,150 | $74.73 | $1.9M | Feb 13, 2026 |
Trades by members of Congress
6 members reported 13 buys and 22 sales since Oct 29, 2024. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Kevin Hern R | Sold | $50K–$100K | Sep 9, 2026 | Sep 25, 2026 | Joint |
| Kevin Hern R | Sold some | $50K–$100K | Sep 4, 2026 | Sep 25, 2026 | Joint |
| Kevin Hern R | Sold | $1,001–$15K | Sep 3, 2026 | Sep 25, 2026 | Child |
| Kevin Hern R | Sold | $1,001–$15K | Sep 3, 2026 | Sep 25, 2026 | Child |
| Kevin Hern R | Sold | $1,001–$15K | Sep 3, 2026 | Sep 25, 2026 | Child |
| Kevin Hern R | Sold | $15K–$50K | Aug 31, 2026 | Sep 25, 2026 | Joint |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Aug 18, 2026 | Sep 10, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Jun 5, 2026 | Jul 2, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Jun 5, 2026 | Jul 2, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | May 29, 2026 | Jun 8, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | May 19, 2026 | Jun 8, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | May 11, 2026 | Jun 8, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Feb 10, 2026 | Mar 9, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Jan 30, 2026 | Feb 13, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Dec 24, 2025 | Jan 12, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Nov 18, 2025 | Dec 15, 2025 | Self |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 31, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Oct 17, 2025 | Nov 18, 2025 | Self |
| Kevin Hern R | Sold some | $15K–$50K | Oct 28, 2025 | Nov 16, 2025 | Joint |
| Val T. Hoyle D | Sold | $1,001–$15K | Sep 23, 2025 | Oct 10, 2025 | Spouse |
| Lisa C. McClain R | Sold some | $1,001–$15K | Aug 4, 2025 | Sep 12, 2025 | Spouse |
| Val T. Hoyle D | Bought | $1,001–$15K | Oct 29, 2024 | Sep 12, 2025318 days later | Spouse |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Jul 31, 2025 | Aug 14, 2025 | Self |
| Lisa C. McClain R | Bought | $1,001–$15K | Dec 11, 2024 | Aug 13, 2025245 days later | Spouse |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Jun 26, 2025 | Jul 10, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Jun 11, 2025 | Jul 10, 2025 | Self |
| Jefferson Shreve R | Sold | $15K–$50K | May 12, 2025 | Jun 22, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | May 13, 2025 | Jun 6, 2025 | Self |
| Bruce Westerman R | Sold | $1,001–$15K | Apr 21, 2025 | May 12, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Apr 28, 2025 | May 6, 2025 | Self |
| Bruce Westerman R | Bought | $1,001–$15K | Mar 3, 2025 | Apr 16, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Mar 17, 2025 | Apr 7, 2025 | Self |
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Feb 24, 2025 | Mar 6, 2025 | Self |
Latest SEC filings
- News filing: Quarterly results 8-K · Oct 28, 2026
- News filing: Executive or board change, Other news 8-K · Oct 7, 2026
- News filing: Executive or board change 8-K · Sep 23, 2026
- News filing: Cybersecurity incident 8-K · Sep 8, 2026
- News filing: Other news 8-K · Aug 26, 2026
- Quarterly report 10-Q · Aug 3, 2026
- News filing: Quarterly results 8-K · Jul 29, 2026
- News filing: Cost cuts or layoffs 8-K · Jul 27, 2026
- News filing: Other news 8-K · May 18, 2026
- News filing: Other news 8-K · May 18, 2026
- News filing: Bylaws or fiscal year changed, Shareholder vote results 8-K · May 5, 2026
- Quarterly report 10-Q · May 1, 2026
- News filing: Quarterly results 8-K · Apr 22, 2026
- News filing: Other news 8-K · Mar 30, 2026
- Shareholder meeting proxy DEF 14A · Mar 18, 2026
- News filing: Signed a major agreement, Ended a major agreement, Took on new debt 8-K · Feb 26, 2026
- News filing: Executive or board change, Public announcement (Reg FD), Other news 8-K · Feb 23, 2026
- Annual report 10-K · Feb 17, 2026
- News filing: Executive or board change 8-K · Feb 5, 2026
- News filing: Quarterly results 8-K · Feb 4, 2026
- Insider plans to sell 144 · Feb 2, 2026
- News filing: Signed a major agreement 8-K · Jan 15, 2026
- News filing: Public announcement (Reg FD) 8-K · Jan 15, 2026
- Insider plans to sell 144 · Dec 1, 2025
- News filing: Executive or board change 8-K · Nov 19, 2025
About Boston Scientific Corp.
Business description
- Industry
- Surgical & Medical Instruments & Apparatus
- Sector
- Industrial Applications and Services
- Headquarters
- Marlborough, MA
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 885725
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.